Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Liss

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|May 10, 2011
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infantsTimo Vesikari, Jason C Martin, Charles L Liss, et al.
International Clinical Psychopharmacology|October 26, 2017
Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European UnionRobert S Brody, Charles L Liss, Heather Wray, et al.
Neurology|November 1, 1989
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's diseaseJ T Hutton, J L Morris, D F Bush, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Enalapril and hydrochlorothiazide as antihypertensive agents in the elderlyD A Shapiro, C L Liss, J F Walker, et al.
Human Vaccines|August 12, 2008
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adultsPierre Van Damme, Gianmaria Minervini, Charles L Liss, et al.
International Clinical Psychopharmacology|October 10, 2015
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studiesRobert S Brody, Charles L Liss, Heather Wray, et al.
Journal of the American College of Cardiology|January 5, 2002
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failureW H Wilson Tang, Randall H Vagelos, Yin Gail Yee, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2014
Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trialAdam L Liss, Merav A Ben-David, Reshma Jagsi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trialR Lindsay, F Cosman, R A Lobo, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|May 10, 2011
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infantsTimo Vesikari, Jason C Martin, Charles L Liss, et al.
International Clinical Psychopharmacology|October 26, 2017
Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European UnionRobert S Brody, Charles L Liss, Heather Wray, et al.
Neurology|November 1, 1989
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's diseaseJ T Hutton, J L Morris, D F Bush, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Enalapril and hydrochlorothiazide as antihypertensive agents in the elderlyD A Shapiro, C L Liss, J F Walker, et al.
Human Vaccines|August 12, 2008
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adultsPierre Van Damme, Gianmaria Minervini, Charles L Liss, et al.
International Clinical Psychopharmacology|October 10, 2015
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studiesRobert S Brody, Charles L Liss, Heather Wray, et al.
Journal of the American College of Cardiology|January 5, 2002
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failureW H Wilson Tang, Randall H Vagelos, Yin Gail Yee, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2014
Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trialAdam L Liss, Merav A Ben-David, Reshma Jagsi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trialR Lindsay, F Cosman, R A Lobo, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
Pageof 8